Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Tax Provisions: 2019-2024

Historic Tax Provisions for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Dec 2024 value amounting to $74.3 million.

  • Harmony Biosciences Holdings' Tax Provisions rose 3.41% to $16.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.8 million, marking a year-over-year increase of 10.06%. This contributed to the annual value of $74.3 million for FY2024, which is 28.21% up from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Tax Provisions of $74.3 million as of FY2024, which was up 28.21% from $58.0 million recorded in FY2023.
  • In the past 5 years, Harmony Biosciences Holdings' Tax Provisions ranged from a high of $74.3 million in FY2024 and a low of -$76.8 million during FY2022.
  • In the last 3 years, Harmony Biosciences Holdings' Tax Provisions had a median value of $58.0 million in 2023 and averaged $18.5 million.
  • Its Tax Provisions has fluctuated over the past 5 years, first surged by 201.11% in 2021, then crashed by 1,283.63% in 2022.
  • Over the past 5 years, Harmony Biosciences Holdings' Tax Provisions (Yearly) stood at -$6.4 million in 2020, then soared by 201.11% to $6.5 million in 2021, then plummeted by 1,283.63% to -$76.8 million in 2022, then soared by 175.49% to $58.0 million in 2023, then rose by 28.21% to $74.3 million in 2024.